Literature DB >> 17073447

The hydrolase and transferase activity of an inverting mutant sialidase using non-natural beta-sialoside substrates.

Jacqueline N Watson1, Deepani Indurugalla, Lydia L Cheng, Arun A Narine, Andrew J Bennet.   

Abstract

The Y370G inverting mutant sialidase from Micromonospora viridifaciens possesses beta-sialidase activity with phenyl beta-sialoside (Ph-betaNeuAc) to give alpha-sialic acid as the first formed product. The derived catalytic rate constants for k(cat) and k(cat)/K(m) are 13.3 +/- 0.3 and (2.9 +/- 0.3) x 10(5) M(-)(1) s(-)(1), respectively. This enzyme is highly specific for the phenyl substrate, with substituted phenyl and thiophenyl leaving groups having k(cat) values that are at least 1000-fold lower. In addition, the Y370G mutant can transfer the sialic acid moiety from Ph-betaNeuAc to lactose in yields of up to 13%. Greater than 90% of the sialyl-lactose product formed in the coupling reactions is the alpha-2,6-isomer. A library encoding 6 x 10(5) different sialidases was constructed by mutating Y370, E260, T309, N310, and N311, residues that include and are proximal the catalytic tyrosine residue. A total of 2628 individuals were screened for hydrolytic activity against 4-nitrophenyl 2-thio-beta-sialoside and 4-methylumbelliferyl beta-sialoside. However, none of the mutants screened possessed a significant activity against either of the beta-sialosides.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073447     DOI: 10.1021/bi061489x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  2 in total

1.  A new sialidase mechanism: bacteriophage K1F endo-sialidase is an inverting glycosidase.

Authors:  Thomas J Morley; Lisa M Willis; Chris Whitfield; Warren W Wakarchuk; Stephen G Withers
Journal:  J Biol Chem       Date:  2009-05-01       Impact factor: 5.157

2.  Sialic acid: a sweet swing between mammalian host and Trypanosoma cruzi.

Authors:  Leonardo Freire-de-Lima; Isadora A Oliveira; Jorge L Neves; Luciana L Penha; Frederico Alisson-Silva; Wagner B Dias; Adriane R Todeschini
Journal:  Front Immunol       Date:  2012-11-29       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.